Systems biology, incorporated?

Nature Biotechnology

Volumn 24, Issue 9, 2006, Pages 1055-1057

  Thiel, Karl ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; PROTEIN P55; PROTEOME; TRANSCRIPTOME; TUMOR NECROSIS FACTOR RECEPTOR; VIRULENCE FACTOR;

BIOTECHNOLOGY; CLINICAL TRIAL; COMMERCIAL PHENOMENA; DRUG MARKETING; GENOME; HUMAN; INFORMATION PROCESSING; PRIORITY JOURNAL; SHORT SURVEY; SIMULATION; SYSTEMS BIOLOGY; ARTICLE; CAPITAL; CLINICAL RESEARCH; DATA COLLECTION METHOD; FINANCIAL MANAGEMENT; INVESTMENT;

BIOTECHNOLOGY; INDUSTRY; SYSTEMS BIOLOGY; UNITED STATES;

EID: 33748512622     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0906-1055     Document Type: Short Survey

References (4)

1. Cook, J. Biotech startup VLST gets $55 million. Seattle Post-Intelligencer June 16, (2006).
2. Lawrence, S. Bioentrepreneur, published online 22 December 2005 (doi:10.1038/bioent897).
3. Thiel, K. Nat. Biotechnol. 22, 1087-1092 (2004).
4. Hendrickson, D. Mass High Tech, published online Sept. 9, 2005 http://masshightech.bizjournals.com/ masshightech/stories/2005/09/12/story5.html